Executive Director, Chief of Staff, Global Development Operations

At Bristol Myers Squibb, our employees often ask, "Who are you working for?"-a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits.

This is work that transforms the lives of patients, and the careers of those who do it.

• Act as a trusted advisor and thought partner to the GDO Head and the GDO LT; help shape strategy, priorities, and key decisions
• Drive development of the GDO strategy and roadmap, annual objectives, and enterprise alignment (Drug Development LT, BMS LT, Board of Directors as needed)
• Identify delivery risks, trade-offs, and opportunities across the portfolio and global footprint, and proactively frame strategic options

• Provide end-to-end visibility across the delivery continuum, from study start-up through close-out, for early and late development
• Establish a single source of truth from the frontline to leadership, with consistent delivery metrics on timelines, enrollment, quality, and cost
• Assess delivery status, risks, and systemic challenges to execution across therapeutic areas and countries
• Lead and facilitate prioritization and resource allocation in partnership with Portfolio Strategy Implementation and Reporting (PSI&R), Development Finance, and Business Insights and Analytics
• Ensure alignment of country enrollment and footprint decisions with enterprise strategy, resourcing, and long-range financial plans

• Convert strategic priorities into integrated, actionable plans across GDO functions, therapeutic areas, and regions
• Drive execution of the GDO transformation roadmap, including the move of Global Trial Managers and Global Trial Leaders into therapeutic area-aligned teams, build-out of TA depth in Tier 1 countries, and stand-up of the centralized risk, compliance, and trial enablement Center of Excellence
• Partner with Transformation & Innovation Operations to embed AI-enabled ways of working and retire manual process
• Track progress against objectives and milestones; ensure risk mitigation, contingency planning, and accountability
• Enable effective execution of integrated Drug Development strategies across Project Leaders, Trial Leadership, and PM

• Lead the GDO LT agenda, governance, and operating rhythm, ensuring focus on highest-value topics and strategic decisions, with a cadence that tracks execution against transformation milestones
• Lead work streams or initiatives to identify solutions to challenges within GDO or across the organization, including single points of accountability across the delivery continuum
• Partner with PSI&R and stakeholders to optimize governance forums and decision quality

• Orchestrate leadership communications across a large, globally distributed organization (town halls, key messaging, change and transformation communications)
• Strengthen team effectiveness, alignment, and follow-through across the GDO LT
• Manage key stakeholder relationships across Drug Development, therapeutic areas, regions, and the enterprise; position GDO as a partner of choice for sites and patients